TABLE 1—
Characteristics | Usual Care (n = 71), % or Mean (SD) | Usual Care + Financial Incentives (n = 75), % or Mean (SD) | All Participants (n = 146), % or Mean (SD) |
Demographic | |||
Age, y | 52.6 (7.4) | 51.7 (7.3) | 52.2 (7.3) |
Gender (female) | 63.4 | 52.0 | 57.5 |
Race/ethnicity, % | |||
Black/African American | 57.7 | 66.7 | 62.3 |
White/Caucasian | 31.0 | 25.3 | 28.1 |
Latino/Hispanic | 4.2 | 6.7 | 5.5 |
Multirace/other | 7.0 | 1.3 | 4.1 |
Partner status (married/living with significant other) | 31.0 | 32.0 | 31.5 |
Socioeconomic | |||
Education, y | 12.1 (1.8) | 12.0 (2.2) | 12.0 (2.0) |
Annual household income (< $12 000) | 52.1 | 58.7 | 55.5 |
Employment status (not employed) | 81.7 | 89.3 | 85.6 |
Insurance status | |||
Uninsured | 52.1 | 52.0 | 52.1 |
Medicaid/Medicare | 39.4 | 40.0 | 39.7 |
Private/job/combination | 8.5 | 8.0 | 8.2 |
Smoking | |||
Cigarettes smoked/d (before quit date) | 17.0 (7.7) | 18.0 (9.7) | 17.5 (8.8) |
Years of smoking | 31.0 (9.6) | 31.9 (9.2) | 31.4 (9.4) |
CO, ppm (baseline) | 17.5 (6.7) | 18.2 (8.6) | 17.9 (7.7) |
Smoke ≤ 5 minutes of waking | 42.3 | 53.3 | 47.9 |
Heaviness of Smoking Index | 3.1 (1.2) | 3.4 (1.3) | 3.3 (1.3) |
Pharmacological treatment | |||
Nicotine replacement therapy | 50.7 | 49.3 | 50.0 |
Varenicline | 32.4 | 37.4 | 34.9 |
Bupropion | 11.3 | 8.0 | 9.6 |
Combination/missing | 5.6 | 5.3 | 5.5 |
Note. CO = carbon monoxide. No significant differences between treatment groups were found on any variable included in the table.